Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot-assisted treadmills help stroke survivors walk again?

NCT ID NCT06497309

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 10, 2026 · Updated 3 times

Summary

This study tested two advanced rehabilitation devices—a treadmill and an overground walking trainer—to help 80 stroke patients regain their ability to walk. Participants used either the C-Mill treadmill or the Andago overground device alongside standard therapy. The goal was to see which approach better improved balance, gait, and independence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that high-tech rehabilitation devices improve walking recovery after stroke better than standard therapy alone.
What could go wrong
This is a small, completed study comparing two similar technologies, so results may not be dramatic or widely applicable. No new drug or cure is being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Jan 2024

Finished

Feb 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hemiparetic patient who has had a stroke; * ischaemic or haemorrhagic stroke confirmed by CT or MRI; * female or male between 40 and 75 years of age; * subgroup 1: less than 3 months since stroke, * subgroup 2: more than 3 months but less than 1 year since stroke; * physical fitness adequate for the exertion of the treatment; * right or left lower limb involvement; * score 3 on the Functional Ambulation Categories (FAC) scale, i.e. Indicates a patient who can ambulate on a level surface without manual contact of another person but requires standby guarding of one person either for safety or verbal cueing; * or score 4 on the Functional Ambulation Categories (FAC) scale, i.e. Indicates a patient who can ambulate independently on a level surface but requires supervision to negotiate (e.g. stairs, inclines, non-flat surfaces); * be able to participate in therapy and cooperate based on cognitive function; * signed informed consent. Exclusion Criteria: * More than 1 year has passed since the stroke; * scores less than or equal to 3 on the Functional Ambulation Categories (FAC) scale; * patients who were unable to walk independently before the stroke; * patients treated with botulinum toxin in the lower limb in the last 3 months; * use of other lower limb advanced technology treatments during the study; * a person with limited capacity; * not physically able to bear weight; * severe aphasia (impairment of understanding or expression that severely impedes communication); * other condition that precludes the use of C-Mill or Andago: * severe emotional disturbance; * mentally incapacitated patient; * severe contracture or spasticity preventing the patient from being placed in the machine; * pregnancy; * skin disease in the area of contact with the straps; * fever; * unhealed fracture fracture; * inability to use the device due to weight and height limitations of the device; * epilepsy if you have had a seizure within a year; * severe visual impairment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gait disorders, neurologic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Gait Disorders, Neurologic stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institute for Medical Rehabilitation

    Budapest, Pest County, 1121, Hungary

More trials for these conditions

Other studies related to the condition(s) this trial covers.